Effectiveness and Safety of Clofarabine Monotherapy or Combination Treatment in Relapsed/Refractory Childhood Acute Lymphoblastic Leukemia: A Pragmatic, Non-interventional Study in Korea.

JY, Choi; CR, Hong; KT, Hong; HJ, Kang; S, Kim; JW, Lee; PS, Jang; NG, Chung; B, Cho; H, Kim; KN, Koh; HJ, Im; JJ, Seo; SM, Hahn; JW, Han; CJ, Lyu; EJ, Yang; YT, Lim; KH, Yoo; HH, Koo; H, Kook; IS, Jeon; H, Cho; HY, Shin

doi:10.4143/crt.2020.289

Public

Effectiveness and Safety of Clofarabine Monotherapy or Combination Treatment in Relapsed/Refractory Childhood Acute Lymphoblastic Leukemia: A Pragmatic, Non-interventional Study in Korea.

Shared by NobleBlocks on Jan 4, 2021 • 12:00 AM UTC

Authors:

Choi JY

Hong CR

Hong KT

Abstract

<h4>Purpose</h4>Effectiveness and safety of clofarabine (one of the treatment mainstays in pediatric patients with relapsed/refractory acute lymphoblastic leukemia [ALL]) was assessed in Korean pediatric patients with ALL to facilitate conditional coverage with evidence development.<h4>Materials and...

Subject

Leukemia

Acute lymphoblastic leukemia

Clofarabine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!